Stevens-Johnson syndrome associated with radiation recall dermatitis in a patient treated with immune checkpoint inhibitor

J Dermatol. 2019 Nov;46(11):e434-e436. doi: 10.1111/1346-8138.15027. Epub 2019 Jul 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antineoplastic Agents, Immunological / adverse effects*
  • Biopsy
  • Chemoradiotherapy / adverse effects*
  • Chemoradiotherapy / methods
  • Ear, External
  • Glucocorticoids / administration & dosage
  • Humans
  • Male
  • Melanoma / pathology
  • Melanoma / therapy
  • Neck
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / therapy
  • Pulse Therapy, Drug
  • Radiodermatitis / diagnosis
  • Radiodermatitis / drug therapy
  • Radiodermatitis / etiology*
  • Radiodermatitis / pathology
  • Skin / drug effects
  • Skin / pathology*
  • Skin / radiation effects
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy
  • Stevens-Johnson Syndrome / diagnosis
  • Stevens-Johnson Syndrome / drug therapy
  • Stevens-Johnson Syndrome / etiology*
  • Stevens-Johnson Syndrome / pathology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Glucocorticoids
  • pembrolizumab